For the Inventor, By the Inventor

Enter assignee name

Sigma-tau Industrie Farmaceutiche Riunite S.p.a.

USPTO Granted Patents = 343

CIPO Patents = 27

EPO Patents = 63

Trademarks = 4

Forward Citations = 1,466

Loading Chart...

Loading Chart...

282 inventors (with patents filed for the assignee):

Maria Ornella Tinti (74 out of 81 patents)

Claudio Cavazza (69 out of 110 patents)

Claudio Pisano (31 out of 38 patents)

4. Piero Melloni (23 out of 47 patents)

5. Mauro Marzi (23 out of 25 patents)

6. Patrizia Ferrari (21 out of 29 patents)

7. Fabio Giannessi (21 out of 21 patents)

8. Giuseppe Giannini (19 out of 26 patents)

9. Domenico Misiti (18 out of 19 patents)

10. Aleardo Koverech (17 out of 18 patents)

11. Loredana Vesci (17 out of 18 patents)

12. Alberto Cerri (17 out of 19 patents)

13. Paolo Carminati (16 out of 37 patents)

14. Piero Foresta (15 out of 17 patents)

15. Francesco De Angelis (15 out of 17 patents)

Core Competencies:

Dietary Supplements

L-Carnitine

Anticancer Compositions

Cardiovascular Disorders

Adenosine A2A Receptor

Fungal Infections

Ophthalmic Drug Delivery

Proteinuria Treatment

Lipid Metabolism Disorders

Thymosin Alpha 1

Retinoid Derivatives

Chronic Venous Insufficiency

343 patents: Sort by Forward Citations

1. 10076541 - Composition useful as a dietary supplement (2018-09-18),

2. 9868757 - 5-β, 14-β-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure (2018-01-16),

3. 9457037 - Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency (2016-10-04),

4. RE45968 - Vector for efficient selection and/or maturation of an antibody and uses thereof (2016-04-11),

5. 9206133 - Process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline (2015-12-08),

6. 9133197 - Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments (2015-09-15),

7. 9125903 - Composition useful for the treatment of lipid metabolism disorders (2015-09-08),

8. 9114120 - Therapeutical method for the treatment of the Leber optic neuropathy (2015-08-25),

9. 9084812 - Composition useful for the prevention or reduction of the progression of prostate cancer (2015-07-21),

10. 9023861 - Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents (2015-05-05),

11. 8975248 - Combinations of therapeutic agents for treating cancer (2015-03-10),

12. 8952059 - Acetyl L-carnitine for the preparation of a medicament for the prevention of painful peripheral neuropathy in patients with type 2 diabetes (2015-02-10),

13. 8927533 - Thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments (2015-01-06),

14. 8883446 - Human long pentraxin 3 expression system and uses thereof (2014-11-11),

15. 8853233 - Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives (2014-10-07),

SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. is a pharmaceutical company based in Italy. They specialize in the research, development, and production of innovative medicines and therapeutics. With a focus on improving health outcomes, they strive to provide effective and safe solutions for various diseases and medical conditions. For more information about their products and services, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

343 Patents

#2 in Rome

#16 in Italy

#2,563 in the World

Sigma-tau Industrie Farmaceutiche Riunite S.p.a.

Forward Citations = 1,466

282 inventors:

Maria Ornella Tinti (74 out of 81 patents)

Claudio Cavazza (69 out of 110 patents)

Claudio Pisano (31 out of 38 patents)

4. Piero Melloni (23 out of 47 patents)

5. Mauro Marzi (23 out of 25 patents)

Please report any incorrect information to support@idiyas.com

Loading…